A cost analysis of alfentanil plus propofol vs morphine plus midazolam for the sedation of critically ill patients

被引:15
|
作者
Manley, NM [1 ]
Fitzpatrick, RW [1 ]
Long, T [1 ]
Jones, PW [1 ]
机构
[1] N STAFFORDSHIRE NHS TRUST,DEPT PHARM,STOKE ON TRENT,STAFFS,ENGLAND
关键词
D O I
10.2165/00019053-199712020-00015
中图分类号
F [经济];
学科分类号
02 ;
摘要
Morphine + midazolam and alfentanil + propofol are regimens offering well tolerated and effective sedation for critically ill patients. However, morphine + midazolam is associated with accumulation in these patients, resulting in prolonged recovery characteristics. Alfentanil + propofol, although more expensive, has a shorter elimination half-life, is not associated with accumulation problems and results in a rapid recovery. This study compared sedation quality, patient recovery characteristics and the cost of alfentanil + propofol and morphine + midazolam for sedating critically ill patients in the intensive care setting. 26 patients were randomly allocated to receive sedation with alfentanil + propofol (n = 17) or morphine + midazolam (n = 9). Outcome measures were the times until extubation, intensive care unit (ICU) transfer and final hospital discharge. Cost analysis assessed both drug-related costs, including drug acquisition and administration, and non-drug-related costs, including bed occupancy. Age, gender, diagnosis, Acute Physiological and Chronic Health Evaluation (APACHE) II scores and sedation quality did not differ significantly between groups. The times to extubation and until patients were fit for transfer from ICU were significantly shorter for patients sedated with alfentanil + propofol than for those sedated with morphine + midazolam. The total costs (at the time of the study pound 1 was equivalent to $US 1.59) for ICU hospital stay per patient for alfentanil + propofol and morphine + midazolam were pound 3063 and pound 9511, respectively, because the shorter recovery characteristics of alfentanil + propofol led to a reduction in ICU stay. Corresponding costs for total hospital stay were pound 6063 and pound 13 735, respectively. In conclusion, alfentanil. + propofol has a better pharmacoeconomic profile than morphine + midazolam for sedating critically ill patients in the ICU setting.
引用
收藏
页码:247 / 255
页数:9
相关论文
共 50 条
  • [1] PROPOFOL VS MIDAZOLAM FOR SEDATION IN CRITICALLY ILL PATIENTS
    BERENYI, T
    MEZOFI, M
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 1995, 74 : 113 - 113
  • [2] Propofol and midazolam for sedation of the critically ill
    Swann, D
    [J]. CRITICAL CARE MEDICINE, 1997, 25 (10) : 1761 - 1761
  • [3] COMPARISON OF PROPOFOL AND MIDAZOLAM FOR SEDATION IN CRITICALLY ILL PATIENTS
    AITKENHEAD, AR
    WILLATTS, SM
    PARK, GR
    COLLINS, CH
    LEDINGHAM, IM
    PEPPERMAN, ML
    COATES, PD
    BODENHAM, AR
    SMITH, MB
    WALLACE, PGM
    [J]. LANCET, 1989, 2 (8665): : 704 - 709
  • [4] EFFECT OF SEDATION WITH ALFENTANIL, MIDAZOLAM OR PROPOFOL ON OXYGEN-TRANSPORT VARIABLES IN THE CRITICALLY ILL
    KOX, W
    BRYDON, C
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 1990, 65 (02) : P278 - P278
  • [5] Comparison of co-sedation with propofol plus midazolam, propofol and midazolam for sedation of patients undergoing mechanical ventilation in the ICU
    Özsezgin, S
    Gökmen, N
    Erdem, Ö
    Arkan, A
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 1999, 82 : 165 - 165
  • [6] Sedation of critically ill patients during mechanical ventilation - A comparison of propofol and midazolam
    Kress, JP
    OConnor, MF
    Pohlman, AS
    Olson, D
    Lavoie, A
    Toledano, A
    Hall, JB
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (03) : 1012 - 1018
  • [7] Pharmacoeconomic modeling of lorazepam, midazolam, and propofol for continuous sedation in critically ill patients
    MacLaren, R
    Sullivan, PW
    [J]. PHARMACOTHERAPY, 2005, 25 (10): : 1319 - 1328
  • [8] Prolonged sedation of critically ill patients with midazolam or propofol: Impact on weaning and costs
    BarrientosVega, R
    SanchezSoria, MM
    MoralesGarcia, C
    RobasGomez, A
    CuenaBoy, R
    AyensaRincon, A
    [J]. CRITICAL CARE MEDICINE, 1997, 25 (01) : 33 - 40
  • [9] Dexmedetomidine vs Midazolam for Sedation of Critically Ill Patients A Randomized Trial
    Riker, Richard R.
    Shehabi, Yahya
    Bokesch, Paula M.
    Ceraso, Daniel
    Wisemandle, Wayne
    Koura, Firas
    Whitten, Patrick
    Margolis, Benjamin D.
    Byrne, Daniel W.
    Ely, E. Wesley
    Rocha, Marcelo G.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (05): : 489 - 499
  • [10] PROPOFOL VS MIDAZOLAM IN SHORT-TERM, MEDIUM-TERM, AND LONG-TERM SEDATION OF CRITICALLY ILL PATIENTS - A COST-BENEFIT-ANALYSIS
    CARRASCO, G
    MOLINA, R
    COSTA, J
    SOLER, JM
    CABRE, L
    [J]. CHEST, 1993, 103 (02) : 557 - 564